Botanical derived progestins and their impact on women's health
植物源孕激素及其对女性健康的影响
基本信息
- 批准号:9105083
- 负责人:
- 金额:$ 35.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAmphiregulinAndrogen ReceptorBindingBiologicalBiological AssayBotanical dietary supplementsBotanicalsBreastCimicifuga racemosaComplex MixturesContraceptive methodsDataDogwoodElementsEmployee StrikesEndometrial CarcinomaEndometriumEpithelial CellsEpitheliumErinaceidaeEstrogensFertilityFibroid TumorFractionationGene Expression RegulationGenetic TranscriptionGingerGlucocorticoid ReceptorHealthHealth BenefitHormonalHormone replacement therapyHormone useHousingHyperplasiaIGFBP2 geneKnowledgeLiteratureLuciferasesMalignant NeoplasmsMalignant neoplasm of ovaryMammary glandMeasuresMenopausal SymptomMessenger RNAMissionModelingMonitorNatural ProductsOregano spicePathologyPhytoestrogensPilot ProjectsPlant ExtractsPlantsPreventionProcessProgesteroneProgesterone ReceptorsProgestinsProteinsRattusReceptor SignalingRegulationReporterReportingResearchRiskSafetyScreening ResultSeriesSignal TransductionSpecificityStromal CellsTestingTissuesTrifolium pratenseUterine CancerUterusVerbenaWomanWomen&aposs HealthWorkYam - dietarybasebiomarker panelbirth controlemergency contraceptionendometriosisestrogenicgene inductionhigh throughput screeningimprovedin vivoinhibitor/antagonistmalignant breast neoplasmpreventpublic health relevancereceptorreceptor bindingresponse
项目摘要
DESCRIPTION (provided by applicant): Virtually all women will use progesterone as a therapy at some point in their lives; despite this, very little research has been conducted on alternative phytoprogestins available in consumable botanical supplements. The breadth of circumstances that employ progestin-containing therapies is striking: endometriosis, fibroids, menopausal symptoms, contraception, and cancers, in all affect hundreds of millions of women worldwide. Botanical dietary supplements are consumed by millions of women. Our preliminary data suggest that the supplements women are consuming contain phytoprogestins that interact with progesterone receptors and modulate hormonal signaling, which if consumed by women could have an impact on various pathologies such as endometriosis, fibroids, fertility modulation, and prevention and treatment of endometrial cancers. Alternatively, women consuming estrogens should use them in combination with progestins to oppose estrogenic action in the uterus that increases the risk of hyperplasia and cancer. From a diverse panel of plants selected based on a series of in house screening results, studies for women's health benefits in the UIC Botanical Center, and a literature report that screened over 150 traditionally used plants for the presence of phytoprogestins, we will synergize with the mission of the UIC Center and test our hypothesis that progesterone-like compounds are present in botanicals and exert tissue-specific gene induction in the breast and uterus. We will 1) Identify the component(s) responsible for the progesterone-like activity in botanicals and develop a high-throughput screen that allows us to detect and identify them from complex mixtures of natural products, 2) Biologically characterize progestins from botanical extracts in regard to their safety
and efficacy by measuring their activation of tissue-specific markers and their specificity for androgen receptors and glucocorticoid receptors, and 3) Elucidate the interaction between phytoprogestins and phytoestrogens on tissue specific gene regulation of the breast and uterus. Since progestins are used for hormone replacement, birth control, emergency contraception, and the treatment of endometriosis, fibroids, and uterine cancer, identifying if and when women are consuming these molecules is critical for their safe and effective use. Women are already exposing themselves to many of these progesterone-like molecules in botanical dietary supplements, and we have no knowledge of where these compounds are present, of their tissue specific effects, or of what their overall impact is on women's health. In order for a woman to safely and effectively use or avoid these compounds, they need to be identified and quantified. This study will provide an important avenue for the identification and characterization of selective natural progesterone compounds from botanical extracts. Therefore, a more focused approach at identifying progestins and characterizing their action - especially from commonly used botanical supplements - is of imminently high impact.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joanna E Burdette其他文献
Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment
- DOI:
10.1186/scrt374 - 发表时间:
2013-12-01 - 期刊:
- 影响因子:7.300
- 作者:
Monica M Laronda;Joanna E Burdette;J Julie Kim;Teresa K Woodruff - 通讯作者:
Teresa K Woodruff
Joanna E Burdette的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joanna E Burdette', 18)}}的其他基金
Development of quantitative mass spectrometry assays and imaging for cancer metastasis
开发癌症转移的定量质谱分析和成像
- 批准号:
10533035 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
- 批准号:
10055916 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
- 批准号:
10393491 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
- 批准号:
10460287 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
- 批准号:
10737811 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
- 批准号:
10672429 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
- 批准号:
10622483 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
高级别浆液性卵巢癌中卵巢-输卵管轴的动态相互作用
- 批准号:
10190857 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
高级别浆液性卵巢癌中卵巢-输卵管轴的动态相互作用
- 批准号:
10667563 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
Microfluidic Models of Ovarian Cancer Preneoplastic Lesions
卵巢癌癌前病变的微流体模型
- 批准号:
10062680 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 35.98万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 35.98万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 35.98万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 35.98万 - 项目类别: